Comparison of the Quantum Blue ® Reader Point-of-Care system versus ELISA technique for therapeutic drug monitoring of Infliximab levels.
CONCLUSIONS: QB is a suitable alternative to Promonitor IFX for TDM in patients treated with IFX for IBD. The results revealed a strong correlation between methods, in particular at lower IFX concentrations, representing the most interesting clinical range. When the samples were stratified according to the therapeutic interval, an almost perfect agreement between the methods was observed.
PMID: 31669514 [PubMed - as supplied by publisher]
Source: Clinical Biochemistry - Category: Biochemistry Authors: Novakovic V, Abdija S, Larsen PB, Fenger M, Gredal L, Jacobsen KK Tags: Clin Biochem Source Type: research
More News: Biochemistry | Denmark Health | Inflammatory Bowel Disease | Remicade | Statistics | Students | Study | Universities & Medical Training